News | July 08, 2007

Zerusa, Vascular Solutions Seal Deal to Distribute Hemostasis Valve in U.S.

July 9, 2007 - Zerusa Limited and Vascular Solutions Inc. announced that they have entered into a distribution agreement in which Vascular Solutions will distribute Zerusa’s Guardian hemostasis valve, which received 510(k) FDA clearance, to develop market acceptance for the valve in the U.S.
The valve is designed to maintain hemostasis during interventional catheterization procedures through a sealing system, which reportedly allows simple introduction and removal of interventional devices with the option to lock wires in place.
Vascular Solutions will launch the valve through its 80-plus employee direct U.S. sales force sometime in July of this year.

For more information: www.vascularsolutions.com and www.zerusa.com

Related Content

nanoparticles, blood clotting, internal bleeding, American Chemical Society study, Erin B. Lavik

Nanoparticles (green) help form clots in an injured liver. The researchers added color to the scanning electron microscopy image after it was taken. Image courtesy of Erin Lavik, Ph.D.

News | Hemostasis Management | August 24, 2016
August 24, 2016 — Whether severe trauma occurs on the battlefield or the highway, saving lives often comes down to...
News | Hemostasis Management | January 06, 2016
The Medicines Company announced Dec. 18 it has entered into a purchase agreement pursuant to which certain subsidiaries...
Overlay Init